Drug Channels Archive for February, 2022

Click a link below to view the mailing archive as if it had been sent to you.

2022-02-25 07:46Drug Channels - Solving the Copay and Best Price Challenge
2022-02-24 07:46Drug Channels News Roundup, February 2022: Mark Cuban vs. Generics, Novo Nordisk's G2N, CVS & 340B, and My Favorite Chart
2022-02-22 07:46Drug Channels - Available for Preorder: The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
2022-02-18 07:46Drug Channels - Vertical Integration: Strategies to Align Care
2022-02-15 07:46Drug Channels - Five Things to Know About the State of Independent Pharmacy Economics
2022-02-11 07:46Drug Channels - Clear Connections for Equitable Medication Access
2022-02-08 07:46Drug Channels - Four Reasons Why PBMs Gain As Maximizers Overtake Copay Accumulators
2022-02-07 07:46Drug Channels - Drug Pricing Transparency Congress
2022-02-04 07:46Drug Channels - A Solution to the Medicare Copay Problem
2022-02-01 07:46Drug Channels - Still Not Skyrocketing: New CMS Data Reinforce the Truth About U.S. Drug Spending


<< Archive IndexSubscribe >>